This compound is a nitrobenzene derivative with a complex polycyclic structure, used primarily as an intermediate in pharmaceutical research and manufacturing. It features multiple amine groups, an ether linkage, and aromatic rings, contributing to its lipophilic and polar characteristics.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1421372-67-9
Mutated EGFR-IN-1
EGFR inhibitor research compound
N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine
pharmaceutical intermediate for osimertinib
2-Bromo-4-fluorotoluene
Pharmaceutical intermediate for synthesis
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol
Pharmaceutical intermediate
(1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol
entecavir intermediate
(3R,4S)-3-FLUOROOXAN-4-OL
Pharmaceutical intermediate for drug synthesis
Mobocertinib
active pharmaceutical ingredient
Mobocertinib succinate
active pharmaceutical ingredient
4-N-[2-(dimethylamino)ethyl]-2-methoxy-4-N-methyl-1-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]-5-nitrobenzene-1,4-diamine
PKEPAQKEINNCAB-UHFFFAOYSA-N
CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=CC(=C(C=C4OC)N(C)CCN(C)C)[N+](=O)[O-]